ASSESS-DHT held its second Sustainability Roundtable on Thursday, November 13th, from 16:00 – 18:00 CET. This meeting was co-organized by empirica and AIHTA, and brought together the project consortium and representatives from all four ASSESS-DHT Use Cases. The focus of the meeting was to look at the current work on the use cases and their role in shaping the draft manual.
The roundtable was moderated by Prof. Claudia Wild of AIHTA, who also introduced the aims of the meeting. This was an interactive roundtable with opportunities for Q&A and discussion after each talk. The first presentation of the day was held by ASSESS-DHT project co-coordinator Juan Carlos Rejón of FPS, who shared an overview of the current status of the ASSESS-DHT Project. This presentation was followed by a talk on the ASSESS-DHT Draft Manual and DHT specialist topics, presented by Zoe Garret of NICE. The attendees applauded the significant work completed on the draft manual since last year’s roundtable and highlighted opportunities to strengthen it.
Felix Broghammer of TUD provided a quick overview of the ASSESS-DHT use cases and their goal within WP5. He emphasized their role as tools for piloting the interim manual and aiding in refining the ASSESS-DHT framework.
The rest of the meeting focused on the four ASSESS-DHT use cases: telehealth, DHA for interoperable data connectivity, AI-based DHT: cardiac implantable device with prediction score, and AI-based technology used in radiology. Each presentation highlighted these tools’ innovative nature, economic and clinical evidence, regulatory compliance, and target population.
Mario Catena of Tech4Care presented the first use case. The presentation introduced the tool DiaWatch, a mobile app for remote monitoring and management of chronic diseases. The second use case was presented by Enric Llopis of Better Care. The tool, BC Link, is software that processes data from medical devices and enables integration with hospital information systems and patient monitoring systems.
The third ASSESS-DHT use case is the Signal-HF tool, a Software as a Medical Device (SaMD) that calculates the risk of heart failure (HF) aggravation using physiological data from compatible cardiac implantable electronic devices (CIEDs) and the patient’s EHR. This tool, developed by Implicity, was presented by Teddy Chupin. The final use case was presented by Georgia Werminghogg Pinto of Radiobotics, who introduced RBfracture. RBfracture is an AI-powered decision support tool, engineered to support Emergency and Radiology clinicians with highly accurate detection of trauma-related findings.
The HTA bodies in attendance had the opportunity to learn more about the project’s use cases and express their needs and questions on these tools.
We thank everyone who joined and contributed to the discussion!